This company could liquidate right now and we would make money! That is just from there balance sheet and not considering there technology rights that BMY could end up paying hundreds of millions on (up to 80mill per drug it is used on)!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.